Literature DB >> 25350739

Complete mitochondrial genome of the Nigeria-Cameroon chimpanzee, Pan troglodytes ellioti (Primates: Hominidae).

Bao-Hua Wang1, Yin-Hua Wang1, Ming-Gui Tang1, Hai-Xia Chai1, Xing-Wei Xuan1, Wei-Yan Guo1, Mu Yang1, Jian-Yi Pu1.   

Abstract

Chimpanzees are especially suited to teach us about ourselves, both in terms of their similarities and differences with human, and such important similarities and differences have also been noted for the incidence and severity of several major human diseases. In the present work, we report the entire mitochondrial genome of the Nigeria-Cameroon chimpanzee (Pan troglodytes ellioti) for the first time. Results shows that this mitogenome is 16,559 bp long and consists of 13 protein-coding genes, 22 transfer RNA genes, 2 ribosomal RNA genes, and 1 putative non-coding region (D-loop region). The genomic organization and gene order are the same as other Chimpanzees. The whole nucleotide base composition is 31.1% of A, 30.7% of C, 12.9% G, and 25.3% T, with a slight A+T bias of 56.4%. Most of the genes are encoded on H-strand, except for the ND6 subunit gene and 8 tRNA genes. The complete mitochondrial genome sequence reported here provides useful genetic information for P. t. ellioti, and will further contribute to the comparative genomics studies in primates.

Entities:  

Keywords:  Mitochondrial genome; nigeria-cameroon chimpanzee; pan troglodytes ellioti

Mesh:

Substances:

Year:  2014        PMID: 25350739     DOI: 10.3109/19401736.2014.974168

Source DB:  PubMed          Journal:  Mitochondrial DNA A DNA Mapp Seq Anal        ISSN: 2470-1394            Impact factor:   1.514


  1 in total

1.  Immunomodulator FTY720 improves glucose homeostasis and diabetic complications by rejuvenation of β-cell function in nonhuman primate model of diabetes.

Authors:  Yixin Jim Wang; Xiaoli Wang; Annie An; Mingfa Zang; Ling Xu; Kefeng Gong; Weihua Song; Qing Li; Xiaojun Lu; Yong-Fu Xiao; Guoliang Yu; Zhongmin A Ma
Journal:  Fundam Clin Pharmacol       Date:  2022-02-02       Impact factor: 2.747

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.